Pantoprazole

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on February 24, 2021.

Return to the list of Patented Medicine Litigation page.





Pantoprazole

PANTO – BYK, PANTO IV, PANTOLOC, TECTA – Nycomed Canada Inc. (NOC Search)

Patents:

  • 1092694: APOTEX
  • 1243215: DOMINION, PHARMEL
  • 1254215: GENPHARM, PHARMASCIENCE, MYLAN, SANDOZ
  • 1330759: SANDOZ
  • 2089748: GENPHARM, TEVA, APOTEX, RATIOPHARM, NOVOPHARM, COBALT, PHARMASCIENCE, SANDOZ
  • 2092694: PHARMASCIENCE, COBALT, SANDOZ, RATIOPHARM, NOVOPHARM, APOTEX, GENPHARM
  • 2109697: TEVA, GENPHARM, SANDOZ, PHARMASCIENCE, TORRENT PHARMA, COBALT, NOVOPHARM, RATIOPHARM
  • 2251636: TEVA
  • 2310585: MYLAN, NOVOPHARM
  • 2341031: TEVA, MYLAN
  • 2428870: PHARMEL, PHARMACEUTICAL PARTNERS, DOMINION, SANDOZ

APOTEX

COBALT

DOMINION

GENPHARM

MYLAN

NOVOPHARM

PHARMACEUTICAL PARTNERS

PHARMASCIENCE

PHARMEL

RATIOPHARM

SANDOZ

TEVA

TORRENT PHARMA


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property